Using advanced imaging to study live cancer cells
Cyclic Immunofluorescent Imaging in Live Cells
['FUNDING_SBIR_1'] · APERTURE BIO, INC. · NIH-11069776
This study is looking at how special imaging tools can help us see live cancer cells in action, which could give us better ideas about how tumors react to different treatments, ultimately helping to tailor therapies for patients like you.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | APERTURE BIO, INC. (nih funded) |
| Locations | 1 site (ALLSTON, UNITED STATES) |
| Trial ID | NIH-11069776 on ClinicalTrials.gov |
What this research studies
This research investigates how advanced imaging techniques can be applied to live cancer cells to better understand their behavior and interactions. By utilizing a unique platform, the study aims to capture dynamic cellular functions and biological processes in real-time, which could help predict how tumors respond to various therapies. The approach focuses on analyzing the tumor microenvironment and its impact on treatment efficacy, potentially leading to improved precision medicine strategies. Patients may benefit from insights gained about their specific cancer types and treatment responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing treatment who are interested in understanding how their tumors may respond to therapies.
Not a fit: Patients with non-cancerous conditions or those not currently receiving cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on individual tumor characteristics.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for cancer studies, indicating a potential for success in this novel approach.
Where this research is happening
ALLSTON, UNITED STATES
- APERTURE BIO, INC. — ALLSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PETERSON, HANNAH MARIE — APERTURE BIO, INC.
- Study coordinator: PETERSON, HANNAH MARIE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: cancer microenvironment, Cancer Patient